QuIC-ConCePT, Quantitative Imaging in Cancer: Connecting Cellular Processes with Therapy, is an Innovative Medicines Initiative (IMI) funded project designed to qualify imaging biomarkers of tumor cell proliferation, apoptosis, and necrosis. A major goal is to enable drug developers to incorporate these imaging biomarkers in Phase I clinical trials of investigational therapies and be confident that the imaging biomarkers are technically valid, that a measured change in the imaging biomarkers faithfully reflects the desired change in the underlying tumor pathology, and that the imaging biomarkers can be readily deployed in multiple cancer centers in a robust, consistent, ethical, and cost-effective way acceptable to the patients who participate in clinical trials.
Jacobs, Andreas Hans | European Institute of Molecular Imaging (EIMI) |
Schober, Otmar | Clinic for Nuclear Medicine |
Jacobs, Andreas Hans | European Institute of Molecular Imaging (EIMI) |
Schober, Otmar | Clinic for Nuclear Medicine |